Jones Trading Maintains Buy on Janux Therapeutics, Lowers Price Target to $28
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Jones Trading analyst Boris Peaker maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and lowers the price target from $50 to $28.
Jones Trading analyst Boris Peaker maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and lowers the price target from $50 to $28.